Oral-Systemic Link: Page 58

Nationwide HPV vaccination program would save billions, extend lives
By Donna Domino
A free, nationwide human papillomavirus (HPV) vaccination program for boys and girls would save billions in medical costs and prevent oropharyngeal cancers, according to the Center for Oral Health. Studies show that noncervical HPV-related diseases cost billions annually, and HPV-related oropharyngeal cancer cases will exceed cervical cancers by 2020.
September 3, 2014
2013 09 03 14 41 25 490 Hpv 200
Blood, saliva tests help predict HPV-linked HNC recurrence
By Donna Domino
Blood and saliva tests can accurately predict the recurrence of human papillomavirus (HPV)-linked head and neck cancers (HNC), according to a recent study in JAMA Otolaryngology -- Head & Neck Surgery. Finding HPV DNA in both blood and saliva samples after treatment accurately predicted recurrence 70% of the time.
August 25, 2014
2013 09 03 14 41 25 490 Hpv 200
Baseball legend Curt Schilling has oral cancer
By DrBicuspid.com staff writers
Former Boston Red Sox pitcher Curt Schilling announced that he has been diagnosed with squamous cell carcinoma, which he attributed to 30 years of chewing tobacco.
August 20, 2014
LSU cancer center offers molecular profiling program
By DrBicuspid.com staff writers
Louisiana State University's (LSU) Health Shreveport Feist-Weiller Cancer Center now offers access to an innovative, precision-medicine technology that determines the unique biological characteristics of each patient's cancer tumor.
August 18, 2014
New imaging agent helps find, remove cancer
By DrBicuspid.com staff writers
Ohio researchers are developing a hybrid imaging agent that makes cancer cells "light up" during surgery. Designed around a peptide called HN1, it has such an affinity for head and neck cancer cells that it's been called a "head and neck cancer homing device."
August 18, 2014
2013 04 10 10 14 48 506 Cancer Cell 200
Researchers develop biomarker panel to detect esophageal cancer
By DrBicuspid.com staff writers
Researchers have developed a four-protein serum biomarker panel that holds promise for the early detection of esophageal cancer, according to a new study in Cancer.
August 11, 2014
2013 12 26 15 30 33 820 Cancer Thru Magnifying Glass 200
Study: Genetic mutations linked to salivary gland tumors
By DrBicuspid.com staff writers
Scientists from the Scripps Research Institute in Florida have found genetic mutations linked to salivary gland tumors, according to a new study in Proceedings of the National Academy of Sciences. The discovery could help develop new treatments that target the cancer's underlying genetic causes.
August 7, 2014
2013 04 19 11 50 16 758 Salivary Glands 200
Survey reveals clinicians' pervasive lack of e-cigarette knowledge
By Rob Goszkowski
The use of e-cigarettes is exploding, and there is lack of knowledge about them among medical professionals. A new survey of doctors and nurses found that the vast majority know very little about e-cigarettes and want to learn more. More than half were uncomfortable discussing the topic with their patients.
August 4, 2014
2014 08 04 15 49 14 150 Ecigarettes 200
Study: Cause of periodontitis related to type 2 diabetes
By DrBicuspid.com staff writers
Modulating the responses of B cells in blood cells may effectively treat or prevent the symptoms of type 2 diabetes and periodontitis simultaneously, according to a new study in the Journal of Leukocyte Biology.
July 31, 2014
Study: Diabetes increases risk for head and neck cancer
By Donna Domino
The risk for head and neck cancer was almost 50% higher in patients with diabetes mellitus than in individuals without diabetes in a new study in JAMA Otolaryngology -- Head & Neck Surgery. The estimated risk for head and neck cancer was also higher for male patients and people ages 40 to 65.
July 31, 2014
2013 05 02 13 20 25 544 Diabetes 200
Quick, low-cost blood test detects early signs of oral cancer
By DrBicuspid.com staff writers
Australian researchers have developed a quick, low-cost blood test to detect the early signs of oral cancer. The test examines the profile of microRNA in the blood and can be done along with routine checks, such as for cholesterol.
July 30, 2014
2013 04 10 10 14 48 506 Cancer Cell 200
Forward Science donates OralID to NC Missions of Mercy
By DrBicuspid.com staff writers
Forward Science Technologies, the developer of OralID and CytID, recently awarded an OralID device to North Carolina Missions of Mercy (NCMOM).
July 28, 2014
Previous Page
Page 58 of 151
Next Page